Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

Condition:   NON-ALCOHOLIC STEATOHEPATITIS Interventions:   Drug: DA-1241;   Drug: Sitagliptin;   Drug: DA-1241 Placebo;   Drug: Sitagliptin Placebo Sponsor:   NeuroBo Pharmaceuticals Inc. Recruiting

Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials